PortfoliosLab logoPortfoliosLab logo
BCHI vs. XC
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

BCHI vs. XC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in GMO Beyond China ETF (BCHI) and WisdomTree Emerging Markets ex-China Fund (XC). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, BCHI achieves a 35.93% return, which is significantly higher than XC's -0.72% return.


BCHI

1D
-0.82%
1M
6.18%
YTD
35.93%
6M
37.59%
1Y
64.74%
3Y*
5Y*
10Y*

XC

1D
-0.28%
1M
1.91%
YTD
-0.72%
6M
-0.57%
1Y
9.24%
3Y*
10.78%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

BCHI vs. XC - Yearly Performance Comparison


2026 (YTD)2025
BCHI
GMO Beyond China ETF
35.93%26.33%
XC
WisdomTree Emerging Markets ex-China Fund
-0.72%17.43%

Correlation

The correlation between BCHI and XC is 0.77, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.77

Correlation (All Time)
Calculated using the full available price history since Feb 13, 2025

0.80

The correlation between BCHI and XC has been stable across timeframes, ranging from 0.77 to 0.80 - a consistent structural relationship.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BCHI vs. XC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BCHI
BCHI Risk / Return Rank: 8888
Overall Rank
BCHI Sharpe Ratio Rank: 9191
Sharpe Ratio Rank
BCHI Sortino Ratio Rank: 8787
Sortino Ratio Rank
BCHI Omega Ratio Rank: 9090
Omega Ratio Rank
BCHI Calmar Ratio Rank: 8686
Calmar Ratio Rank
BCHI Martin Ratio Rank: 8787
Martin Ratio Rank

XC
XC Risk / Return Rank: 1818
Overall Rank
XC Sharpe Ratio Rank: 1919
Sharpe Ratio Rank
XC Sortino Ratio Rank: 1818
Sortino Ratio Rank
XC Omega Ratio Rank: 1818
Omega Ratio Rank
XC Calmar Ratio Rank: 1818
Calmar Ratio Rank
XC Martin Ratio Rank: 1818
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BCHI vs. XC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for GMO Beyond China ETF (BCHI) and WisdomTree Emerging Markets ex-China Fund (XC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


BCHIXCDifference
Sharpe ratioReturn per unit of total volatility

+2.36

Sortino ratioReturn per unit of downside risk

+2.79

Omega ratioGain probability vs. loss probability

1.55

1.12

+0.43

Calmar ratioReturn relative to maximum drawdown

4.60

0.74

+3.86

Martin ratioReturn relative to average drawdown

17.73

1.98

+15.75

BCHI vs. XC - Sharpe Ratio Comparison

The current BCHI Sharpe Ratio is 2.98, which is higher than the XC Sharpe Ratio of 0.62. The chart below compares the historical Sharpe Ratios of BCHI and XC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

BCHI vs. XC - Drawdown Comparison

The maximum BCHI drawdown since its inception was -14.33%, smaller than the maximum XC drawdown of -20.97%. Use the drawdown chart below to compare losses from any high point for BCHI and XC.


Loading charts...

Drawdown Indicators


BCHIXCDifference

Max Drawdown

Largest peak-to-trough decline

-14.33%

-20.97%

+6.64%

Max Drawdown (1Y)

Largest decline over 1 year

-14.14%

-12.47%

-1.67%

Max Drawdown (3Y)

Largest decline over 3 years

-20.97%

Current Drawdown

Current decline from peak

-1.09%

-6.77%

+5.68%

Average Drawdown

Average peak-to-trough decline

-2.26%

-4.16%

+1.90%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.66%

4.67%

-1.01%

Volatility

BCHI vs. XC - Volatility Comparison

GMO Beyond China ETF (BCHI) has a higher volatility of 11.10% compared to WisdomTree Emerging Markets ex-China Fund (XC) at 4.85%. This indicates that BCHI's price experiences larger fluctuations and is considered to be riskier than XC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


BCHIXCDifference

Volatility (1M)

Calculated over the trailing 1-month period

11.10%

4.85%

+6.25%

Volatility (6M)

Calculated over the trailing 6-month period

19.96%

13.18%

+6.78%

Volatility (1Y)

Calculated over the trailing 1-year period

21.88%

15.06%

+6.82%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

21.77%

15.91%

+5.86%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

21.77%

15.91%

+5.86%

BCHI vs. XC - Expense Ratio Comparison

BCHI has a 0.65% expense ratio, which is higher than XC's 0.32% expense ratio.


Dividends

BCHI vs. XC - Dividend Comparison

BCHI's dividend yield for the trailing twelve months is around 2.70%, less than XC's 12.07% yield.


PositionTTM2025202420232022
BCHI
GMO Beyond China ETF
2.70%3.67%0.00%0.00%0.00%
XC
WisdomTree Emerging Markets ex-China Fund
12.07%11.74%1.49%1.42%0.57%

Frequently Asked Questions


BCHI and XC have a correlation of 0.77, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BCHI has higher volatility (11.10%) compared to XC (4.85%). In terms of maximum drawdown, BCHI dropped -14.33% vs XC's -20.97%.

On 1-year performance, BCHI leads with 64.74% vs 9.24% for XC. On fees, XC is cheaper at 0.32% per year. On volatility, XC has been the lower-risk option at 4.85%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 1-year period, BCHI has performed better with a 64.74% return vs 9.24%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

XC is cheaper with a 0.32% expense ratio, compared with 0.65% for BCHI.

XC has the higher dividend yield at 12.07%, compared with 2.70% for BCHI.

They also come from different issuers: GMO and WisdomTree. Their fees differ too: 0.65% for BCHI and 0.32% for XC.

BCHI currently has the higher Sharpe Ratio (2.98 vs 0.62), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for BCHI and XC

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer